Trinity Medical is a business focused on a new paradigm for building value in the commodity and specialty medical device market through a uniquely conceived vertically integrated business model
Trinity Medical Devices Inc. is a business focused on a new paradigm for building value in the commodity medical device market through a uniquely conceived vertically integrated business model.
Every year more and more medical products move from the category of “specialty” to “commodity”. Buyers such as Hospitals, Governments and Brand Name Corporations who source these products, recognize spending for these commodity products has skyrocketed, and they are desperately searching for options.
While many organizations have large purchasing departments, their cumbersome qualification systems slow them down and add significant internal costs. It becomes more economical for them to qualify Trinity Medical, than to seek out and qualify multiple suppliers. Most could receive a lower cost if they could buy direct from manufacturers. However, there are credibility, regulatory, communication, logistical, and customer service barriers. Depending on your organization structure, overcoming these barriers can be very costly. Ultimately, the Healthcare delivery system pays the price.
Many large companies are forced to burden their commodity products with considerably higher overhead due to the wide range of specialty products they carry, Research and Development, and large overlapping Sales Forces.
This paves the way for Trinity Medical Devices, the world’s first generic medical device company focused on commodities.
Trinity Medical Devices is ISO13485:2016 certified through TUV, and FDA registered.
Board of Directors
Mr. Dimun is a serial entrepreneur with more than 30 years of successful operational, business development, and financial experience in the healthcare marketplace. During the last 20 years, Mr. Dimun has been a founder, investor, director, and mentor to over 21 emerging growth medical enterprises that have matured to commercial status. Of these enterprises, four became public companies and eleven were acquired.
Since 2001, Mr. Dimun has served as Chairman and Founder of Nascent Enterprises, a group of medical industry entrepreneurs focused on successful commercialization of promising medical device inventions. From 1987 to 2001, he served as Executive Vice President & Chief Financial Officer and member of the BOD of Vital Signs, a publicly held anesthesia, respiratory and sleep apnea medical device business. GE Healthcare acquired Vital Signs in 2008 for approximately $900 million. Prior to 1991, Mr. Dimun held positions as a Certified Public Accountant with national accounting firms and served as Senior Vice President for an international merchant banking firm specializing in mergers & acquisitions.
Mr. Dimun has been a director of several public companies, including MELA Sciences, Vital Signs, Bionx Implants, Colorado MedTech, Photomedix, ISS Surgical Systems and other numerous privately held companies in the healthcare industry. He has also served on the Board of Advisors of the Rutgers University Technology Center & the Biomaterial Institute of Rutgers University and, through Nascent Enterprises, provides the University of Pennsylvania and other universities with entrepreneurial assistance to commercialize their medical technology.
Since founding the company in 1998, Jerry Miller has guided the growth of The Miller Group and its affiliated companies as Owner and CEO. A 1977 graduate of the United States Naval Academy, he also served seven years as a Surface Warfare Officer. Jerry co-founded Earl Industries in 1985 and purchased the company outright in 1989 leading the company through many years of success and ultimately to its sale to General Dynamics in 2012.
Mr. Miller is a serial entrepreneur with various successful ventures across different industries.
Experience:
Willow Edge Advisors LLC
Managing Director & Principal
Company Name: Willow Edge Advisors LLC
Dates Employed: Apr 2015 – Present
Employment Duration: 2 years 8 months
Strategic adviser and angel investor to life science start-ups and acquisitions and divestitures.
Johnson & Johnson
Global Treasurer
Company Name: Johnson & Johnson
Dates Employed: May 1977 – Oct 2015
Employment Duration: 38 years 6 months
Responsibilities included capital structuring, cash and debt management, foreign exchange, mergers and acquisitions, risk management, defined benefit/defined contribution plan asset management, and incentive compensation management.
Total assets under management were in excess of $80 billion.
For more than 20 years, David L. Bernd served as the Chief Executive Officer of Sentara Healthcare, a $4.7 billion integrated health system headquartered in Norfolk, Va., comprised of 12 acute-care hospitals, with health plans covering 450,000 lives, 950+ provider medical groups and medical staffs of approximately 3,700 physicians. Under his leadership, Sentara has developed a national reputation for safety, quality, and innovation, and Sentara facilities and programs have even been recognized in the America’s Best Hospital’s rankings by U.S. News & World Report for the past 15 years. Mr. Bernd led the organization into a new era of health care, caring for defined populations and transforming the way health care is provided.
Sentara is an innovator utilizing technology to enhance clinical outcomes. Sentara launched the nation’s first electronic intensive care unit (eICU®) system in 2000 to remotely monitor ICU patients across multiple hospitals. In 2002, Sentara reported a reduction in hospital mortality of 26%, with a 17% decrease in ICU length of stay (LOS). Named as one of the top wired health care systems for four consecutive years in Hospitals and Health Networks, Sentara is connecting its hospitals, pharmacists, physicians, nurses, radiologists, long-term care providers and medical transport resources in a seamless communication system called the Sentara eCare Health Network®, an industry-leading electronic medical record. Mr. Bernd was recognized for his commitment to information technology with the 2010 CEO IT Achievement Award by Modern Healthcare. In recognition of the dramatic clinic results achieved through deployment of Sentara eCare®, Sentara also earned the HIMSS Davies Award and HIMSS Stage 7 Award in 2010.
Mr. Bernd received his Master of Hospital and Health Administration from the Medical College of Virginia in 1973. He served his residency at Norfolk General Hospital (today Sentara Norfolk General Hospital) from 1972-73. Mr. Bernd served as assistant administrator at Norfolk General Hospital from 1973 until 1979 when he was named administrator and was the 1984 recipient of the American College of Hospital Administrators’ Robert S. Hudgens National Young Hospital Administrator of the Year Award. In 1985 Mr. Bernd was named executive vice-president/chief operating officer of Sentara Health System and president, Sentara Hospitals-Norfolk. In December 1994, he was named Chief Executive Officer of Sentara Health System (now Sentara Healthcare), assuming the role in March 1995.
Mr. Bernd, was named by the U.S. Secretary of Commerce to serve as a member of the Measuring Innovation in the 21st Century Economy Advisory Committee of the Department of Commerce in 2006-2007. He was Chair of the VHHA Board of Directors from November 1994-October 1995, and in 2004, Mr. Bernd served as chairman of the American Hospital Association Board of Trustees, making him the top elected official of the largest hospital and health system association in the United States.
In addition, Mr. Bernd served on the Board of Visitors at Old Dominion (Rector from 2010 – 2012). He has also served on the VHA, Inc. Board of Directors, and in October, 2014, Mr. Bernd was appointed by the Secretary of the Army as a Civilian Aide to the Secretary of the Army. He is past Chairman of the United Way of South Hampton Roads Board of Directors and the Metropolitan Board of YMCA of South Hampton Roads.
Blakely Page, a strategic advisor and investor, is a Managing Partner at Spouting Rock Financial Partners where he is in constant search for “Best Ideas” investments. His focus is identifying high quality leaders and entrepreneurs that have a proven track record of being successful. Previously, he was Principal with Bank of America Securities where he focused on middle market initiatives.
Blakely began his career at Morgan Stanley in Private Wealth Management and later moved to Institutional Equities. At Thomas Weisel Partners, he specialized in hedge funds and while at Susquehanna Financial Group, he helped build their institutional brokerage platform. Blakely received his B.A. from Southern Methodist University. FINRA Series 7, 24, 63, and 79 licenses.
Management Team
Mr. Dimun is a serial entrepreneur with more than 30 years of successful operational, business development, and financial experience in the healthcare marketplace. During the last 20 years, Mr. Dimun has been a founder, investor, director, and mentor to over 21 emerging growth medical enterprises that have matured to commercial status. Of these enterprises, four became public companies and eleven were acquired.
Since 2001, Mr. Dimun has served as Chairman and Founder of Nascent Enterprises, a group of medical industry entrepreneurs focused on successful commercialization of promising medical device inventions. From 1987 to 2001, he served as Executive Vice President & Chief Financial Officer and member of the BOD of Vital Signs, a publicly held anesthesia, respiratory and sleep apnea medical device business. GE Healthcare acquired Vital Signs in 2008 for approximately $900 million. Prior to 1991, Mr. Dimun held positions as a Certified Public Accountant with national accounting firms and served as Senior Vice President for an international merchant banking firm specializing in mergers & acquisitions.
Mr. Dimun has been a director of several public companies, including MELA Sciences, Vital Signs, Bionx Implants, Colorado MedTech, Photomedix, ISS Surgical Systems and other numerous privately held companies in the healthcare industry. He has also served on the Board of Advisors of the Rutgers University Technology Center & the Biomaterial Institute of Rutgers University and, through Nascent Enterprises, provides the University of Pennsylvania and other universities with entrepreneurial assistance to commercialize their medical technology.
Mr. Jefferson has over 25 years’ experience in the Medical Device industry having senior executive leadership roles. He was recently with Vital Signs, Inc, a GE Healthcare Company for most of those years, where he held various positions from National Account Management, to Vice President of Sales & Marketing. He not only witnessed the birth of Group Purchasing Organizations, Integrated Delivery & Healthcare Networks, but has been involved with their evolution. Mr. Jefferson was instrumental in winning and maintaining contracts, and he has long standing relationships with these organizations.
His skills and experience encompass the management of Sales and Marketing teams, Customer Service and the Order-to-Revenue process. Mr. Jefferson has also been involved with Business Development opportunities, establishing long-term relationships through product licensing, acquisitions and distribution partnerships. Special emphasis includes his work with all US distribution channel networks. His wide breadth of product knowledge ranges from the Anesthesia, Respiratory and Critical Care areas.
Mr. Jefferson has his BS from Ball State University.
Mr. Kennedy is one of the original founding members of Trinity Medical Devices.
An improvement obsessed Operations Professional with 38+ years of unparalleled experience in Global Medical Device Manufacturing & Distribution. A substantial portion of Mr. Kennedy’s experience was acquired while growing with the Market Leader, Vital Signs Inc. – a GE Healthcare Company, from the early start up stages through the ultimate achievement as a world leader in disposable Anesthesia and Respiratory supplies.
Having held numerous senior executive positions, Mr. Kennedy’s experience covers Operations, Materials Management, Sourcing, Supply Chain Management, Inventory Control/Warehouse Control, Capacity Management, Logistics, Internal Auditing, and QMS Implementation.
Mr. Kennedy was instrumental throughout the process of the Marquest, Thermadrape, Actar, and Broselow acquisitions and was actively involved in cost savings programs throughout the Global Supply Chain. He played an important role in the integration process of Vital Signs to GE post acquisition in the functions of Sourcing, Supplier Qualification, Systems Integration, and Documentation Control.
Through his career Mr. Kennedy’s focus has been in airway management, primarily single patient use anesthesia, respiratory, and critical care products.
Mr. Kennedy has a recognized ability to exceed the needs and expectations of this dynamic and demanding business through flexible managerial/leadership abilities, strategic Operations and Supply Chain capabilities, analytical skills, and a world class network of Sourcing contacts in the medical consumables market.
Having joined Trinity Medical Devices in January of 2013, Mr. Kennedy established and implemented the necessary procedures that allowed the company to be ISO 13485:2003 certified by October 29, 2013.
Special training includes Lean, Change Acceleration Process, Employee Health and Safety, Human and Organizational Performance (HOP), and as an Internal ISO 13485 Auditor.
Mr. Kennedy holds a BS in Business Management from Fairleigh Dickinson University.
Ms. Chertok brings 25+ years of business savvy to work every day at Trinity Medical Devices. Her strong skill set includes financial reporting and project management. Ms. Chertok began her career at Reich and Tang LP in their operations group. She worked with Chase Manhattan Bank and continued her successful career at Fidelity Investments/Prime Services Group in various departments, working her way up from Analyst to Implementation Manager in only a few short years. Then, Ms. Chertok took a break from the financial industry and worked with a non-profit agency.
Ms. Chertok prides herself on building long term client relationships to maximize potential growth and benefit for both parties.
Ms. Chertok holds a Bachelor’s Degree in Finance from The University of Maryland–College Park.
Ms. Natali has over 30 years’ experience in the areas of finance, software, and office management. Her experience ranges from handling the loan account for a major bank to 16 years as the sole finance/accounting individual for one of the most successful franchises of Seko Logistics. She currently oversees all aspects of Sage software for Trinity, manages the full range of customer service needs, as well as being the finance assistant to Ms. Chertok.
Mr. Hu has over 15 years’ experience in Operations, Finance, Sales & Marketing, Distribution and International Logistics in the Medical Device Industry. He has been focused in China and East Asia, including responsibility for the overall operations in China for Vital Signs, Inc., a GE Healthcare Company. In the position of Vital Signs China Country Manager, he was a leader in establishing and managing the Vital Signs Joint Venture manufacturing operation in Shenzhen, China which produced products critical to Vital Signs core business. Mr. Hu also implemented Vital Signs Sales and Distribution organization in the China region and has strong relationships with distributors and manufacturers.
Mr. Hu holds a Bachelor of Commerce from the University of Auckland and a Bachelor of Engineering from GDI University.